Phenominer Database Results (79 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Average Type Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Clinical Measurement Notes Experiment Notes Record ID Study ID
MWF/ZtmRrrc hematocrit enalapril (50 mg/l) (for 60 days) Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. erythrocyte quantity male 126 days 10 51.0 % 0.32 1.0 hematocrit analysis 0.0 0 100914 2541
WKY hematocrit 0.9% sodium chloride solution (3 ml) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. erythrocyte quantity male 0 days 8 45.0 % 1.0 2.83 hematocrit analysis 0.0 0 100439 2479
WKY hematocrit puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. erythrocyte quantity male 0 days 9 43.0 % 1.0 3.0 hematocrit analysis 0.0 PA IV 50mg/kg 0 100440 2479
MW hematocrit right nephrectomy (for 56 days) then angiotensin II receptor antagonist (80 mg/l) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. erythrocyte quantity male 0 days 5 45.0 % 1.1 2.46 hematocrit analysis 0.0 ~5/6 to 7/8 nephrectomy 56 days 100854 2523
MW hematocrit right nephrectomy (for 112 days) then reserpine (5 mg/l) (for 56 days) and hydralazine (80 mg/l) (for 56 days) and controlled hydralazine content drinking water (25 mg/l) (for 56 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. erythrocyte quantity male 0 days 10 45.8 % 0.7 2.21 hematocrit analysis 0.0 ~5/6 to 7/8 nephrectomy 112 days 100856 2523
MW hematocrit right nephrectomy (for 112 days) then captopril (30 mg/kg/d) (for 56 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. erythrocyte quantity male 0 days 10 45.3 % 1.1 3.48 hematocrit analysis 0.0 ~5/6 to 7/8 nephrectomy 112 days 100857 2523
MW hematocrit right nephrectomy (for 112 days) then angiotensin II receptor antagonist (80 mg/l) (for 56 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. erythrocyte quantity male 0 days 5 41.0 % 1.9 4.25 hematocrit analysis 0.0 ~5/6 to 7/8 nephrectomy 112 days 100861 2523
MW hematocrit right nephrectomy (for 56 days) then captopril (30 mg/kg/d) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. erythrocyte quantity male 0 days 10 46.7 % 0.8 2.53 hematocrit analysis 0.0 ~5/6 to 7/8 nephrectomy 56 days 100850 2523
SD-Cftrem2Apb mean corpuscular volume controlled ColonLYTELY content drinking water (4.5 %) McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. erythrocyte size trait not specified 0 days 0 63.0 fl 0.0 hematocrit analysis 0.0 0 111446 3184
HsdCpb:WU hematocrit left anterior descending coronary artery occlusion Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. erythrocyte quantity male 175 days 5 48.7 % 1.0 2.24 hematocrit analysis 0.0 0 108862 3130
MWF/Hsd hematocrit left anterior descending coronary artery occlusion Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. erythrocyte quantity male 175 days 9 45.7 % 0.7 2.1 hematocrit analysis 0.0 0 108863 3130
SD-Cftrem2Apb hematocrit controlled ColonLYTELY content drinking water (4.5 %) McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. erythrocyte quantity not specified 0 days 0 48.0 % 4.0 hematocrit analysis 0.0 0 111449 3184
MWF/Hsd hematocrit left anterior descending coronary artery occlusion Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. erythrocyte quantity male 175 days 10 45.7 % 0.7 2.21 hematocrit analysis 0.0 0 108805 3130
SHRSP.WKY-(D1Wox29-D1Arb21)/Izm hematocrit control condition Yao H, et al., Physiol Genomics. 2007 Feb 27;. erythrocyte quantity male 150 days 9 45.0 % 0.67 2.0 hematocrit analysis 0 0 65525 567
F344/NHsd hematocrit air oxygen content (10 %) (for 21 days) Zhao L et al., 2001, Circulation, 103(3), 442-7 erythrocyte quantity male 105 days 23 median 70.0 % hematocrit analysis 0 0 66132 102
WKY/NCruk hematocrit control condition Zhao L et al., 2001, Circulation, 103(3), 442-7 erythrocyte quantity male 105 days 12 median 45.0 % hematocrit analysis 0 0 66133 102
SS/JrHsdMcwi hematocrit controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. erythrocyte quantity female 89 days-92 days 15 38.8 % 1.4 5.42 hematocrit analysis 0.0 0 69482 151
WKY hematocrit unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. erythrocyte quantity male 0 days 17 44.8 % 0.6 2.47 hematocrit analysis 0.0 unx 168 days 99976 2378
WKY hematocrit unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days) Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. erythrocyte quantity male 0 days 17 45.6 % 0.3 1.24 hematocrit analysis 0.0 unx 168 days 99977 2378
MW hematocrit nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. erythrocyte quantity male 0 days 8 36.0 % 1.0 2.83 hematocrit analysis 0.0 5/6 nephrectomy 28 days 100988 2561
SR/Jr hematocrit controlled sodium chloride content diet (0.3 %) (for 35 days) Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404. erythrocyte quantity male 63 days 16 45.8 % 0.4 1.6 hematocrit analysis 0.0 0 103266 2802
SS/Jr hematocrit controlled sodium chloride content diet (8 %) (for 35 days) Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404. erythrocyte quantity male 63 days 10 47.0 % 2.2 6.96 hematocrit analysis 0.0 0 103269 2802
SR/Hsd hematocrit aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. erythrocyte quantity male 49 days-56 days 0 39.0 % 2.0 hematocrit analysis 0.0 0 - 103231 2801
MWF/ZtmRrrc hematocrit control condition Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. erythrocyte quantity male 126 days 8 50.0 % 0.35 1.0 hematocrit analysis 0.0 0 100913 2541
WKY hematocrit controlled enalapril content drinking water (50 mg/l) (between 63 and 77 days) then puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. erythrocyte quantity male 0 days 8 43.0 % 1.0 2.83 hematocrit analysis 0.0 PA IV 50mg/kg 0 100441 2479
MW hematocrit right nephrectomy (for 56 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. erythrocyte quantity male 0 days 6 44.8 % 0.6 1.47 hematocrit analysis 0.0 ~5/6 to 7/8 nephrectomy 56 days 100848 2523
MWF/Ztm hematocrit arterial catheter implantation and controlled hemorrhage Remuzzi A, etal., Kidney Int. 1988 Oct;34(4):481-6. doi: 10.1038/ki.1988.206. erythrocyte quantity female 126 days-147 days 8 47.7 % 0.49 1.4 hematocrit analysis 0.0 0 109206 3138
HsdCpb:WU hematocrit left anterior descending coronary artery occlusion Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. erythrocyte quantity male 175 days 6 48.7 % 1.0 2.45 hematocrit analysis 0.0 0 108803 3130
WKY hematocrit unilateral nephrectomy (for 28 days) then vehicle control condition Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. erythrocyte quantity male 0 days 11 45.2 % 1.4 4.64 hematocrit analysis 0.0 unx 168 days 99975 2378
WKY hematocrit unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. erythrocyte quantity male 0 days 16 45.8 % 0.5 2.0 hematocrit analysis 0.0 unx 168 days 99978 2378
SS/Hsd hematocrit artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. erythrocyte quantity male 49 days-56 days 0 41.0 % 2.0 hematocrit analysis 0.0 0 - 103232 2801
MW hematocrit nephrectomy (for 28 days) then enalapril (50 mg/l) (for 21 days) Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. erythrocyte quantity male 0 days 8 38.0 % 1.0 2.83 hematocrit analysis 0.0 5/6 nephrectomy 28 days 100987 2561
SHRSP/Izm hematocrit control condition Yao H, et al., Physiol Genomics. 2007 Feb 27;. erythrocyte quantity male 70 days-84 days 8 42.0 % 0.71 2.0 hematocrit analysis 0 0 65523 567
SHRSP/Izm hematocrit control condition Yao H, et al., Physiol Genomics. 2007 Feb 27;. erythrocyte quantity male 150 days 7 44.0 % 1.13 3.0 hematocrit analysis 0 0 65524 567
F344/NHsd hematocrit control condition Zhao L et al., 2001, Circulation, 103(3), 442-7 erythrocyte quantity male 105 days 12 median 46.0 % hematocrit analysis 0 0 66131 102
BN/NHsdMcwi hematocrit controlled sodium content diet (0.4 %) (for 35 days) then controlled sodium content diet (0.1 %) (for 35 days) then controlled sodium content diet (8 %) (between 22 and 24 days) Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. erythrocyte quantity female 89 days-92 days 15 41.6 % 0.4 1.55 hematocrit analysis 0.0 0 69481 151
SD hematocrit control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. erythrocyte quantity male 420 days-450 days 9 45.0 % 1.0 3.0 hematocrit analysis 0.0 0 101221 2582
SS/Jr hematocrit controlled sodium chloride content diet (0.3 %) (for 35 days) Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404. erythrocyte quantity male 63 days 15 48.8 % 0.5 1.94 hematocrit analysis 0.0 0 103268 2802
SS/Hsd hematocrit aldosterone (22.5 ng/hr) (for 14 days) and artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. erythrocyte quantity male 49 days-56 days 0 40.0 % 3.0 hematocrit analysis 0.0 0 - 103233 2801
WKY hematocrit controlled enalapril content drinking water (50 mg/l) (for 30 days) then puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. erythrocyte quantity male 0 days 5 35.0 % 1.0 2.24 hematocrit analysis 0.0 PA IV 50mg/kg 23 days 100438 2479
WKY hematocrit controlled enalapril content drinking water (50 mg/l) (for 497 days) then puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. erythrocyte quantity male 0 days 9 42.0 % 1.0 3.0 hematocrit analysis 0.0 PA IV 50mg/kg 490 days 100444 2479
MW hematocrit right nephrectomy (for 56 days) then lisinopril (10 mg/kg/d) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. erythrocyte quantity male 0 days 10 44.0 % 1.0 3.16 hematocrit analysis 0.0 ~5/6 to 7/8 nephrectomy 56 days 100852 2523
MW hematocrit right nephrectomy (for 112 days) then angiotensin II receptor antagonist (20 mg/l) (for 56 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. erythrocyte quantity male 0 days 7 40.5 % 2.1 5.56 hematocrit analysis 0.0 ~5/6 to 7/8 nephrectomy 112 days 100860 2523
MW hematocrit right nephrectomy (for 56 days) then reserpine (5 mg/l) and hydralazine (80 mg/l) and controlled hydralazine content drinking water (25 mg/l) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. erythrocyte quantity male 0 days 10 48.4 % 1.4 4.43 hematocrit analysis 0.0 ~5/6 to 7/8 nephrectomy 56 days 100849 2523
MWF hematocrit castor oil Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4. erythrocyte quantity male 133 days-147 days 7 45.0 % 1.13 3.0 hematocrit analysis 0.0 0 110018 3163
BDIX/CrCrl hematocrit DHD/K12/TRb cells (1.5 X 10E6) then vehicle control condition (1 ml) Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. erythrocyte quantity male 71 days 10 52.3 % 0.95 3.0 hematocrit analysis 0.0 0 red blood cell count, hematocrit 107811 3097
BDIX/CrCrl hematocrit DHD/K12/TRb cells (1.5 X 10E6) then vehicle control condition (1 ml) Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. erythrocyte quantity male 92 days 10 51.0 % 1.04 3.3 hematocrit analysis 0.0 0 red blood cell count, hematocrit 107813 3097
BDIX/CrCrl hematocrit DHD/K12/TRb cells (1.5 X 10E6) then sanguinarine (5 mg/kg/d) Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. erythrocyte quantity male 92 days 10 44.0 % 0.98 3.1 hematocrit analysis 0.0 0 red blood cell count, hematocrit 107814 3097
MWF/Hsd hematocrit control condition Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. erythrocyte quantity male 84 days 5 44.2 % 0.3 0.67 hematocrit analysis 0.0 0 108785 3130
MWF/Ztm hematocrit arterial catheter implantation and controlled hemorrhage Remuzzi A, etal., Kidney Int. 1988 Oct;34(4):481-6. doi: 10.1038/ki.1988.206. erythrocyte quantity male 112 days-147 days 8 49.5 % 0.42 1.2 hematocrit analysis 0.0 0 109205 3138
Sah:SD hematocrit control condition McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. erythrocyte quantity not specified 0 days 0 49.0 % 2.0 hematocrit analysis 0.0 0 111447 3184
MHS/Gib hematocrit control condition Ferrari P, etal., J Hypertens. 1987 Apr;5(2):199-206. doi: 10.1097/00004872-198704000-00011. erythrocyte quantity not specified 50 days-70 days 6 46.4 % 0.7 1.71 hematocrit analysis 0.0 0 110327 3169
WKY/NCruk hematocrit air oxygen content (10 %) (for 21 days) Zhao L et al., 2001, Circulation, 103(3), 442-7 erythrocyte quantity male 105 days 28 median 71.0 % hematocrit analysis 0 0 66134 102
WKY hematocrit unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days) Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. erythrocyte quantity male 0 days 16 44.5 % 0.6 2.4 hematocrit analysis 0.0 unx 168 days 99979 2378
SD hematocrit control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. erythrocyte quantity male 90 days 9 46.0 % 1.0 3.0 hematocrit analysis 0.0 0 101220 2582
MW hematocrit nephrectomy (for 28 days) then control condition Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. erythrocyte quantity male 0 days 8 40.0 % 1.0 2.83 hematocrit analysis 0.0 5/6 nephrectomy 28 days 100986 2561
WKY hematocrit 0.9% sodium chloride solution (3 ml) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. erythrocyte quantity male 0 days 9 41.0 % 1.0 3.0 hematocrit analysis 0.0 0 100436 2479
WKY hematocrit puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. erythrocyte quantity male 0 days 7 39.0 % 1.0 2.65 hematocrit analysis 0.0 PA IV 50mg/kg 23 days 100437 2479
WKY hematocrit 0.9% sodium chloride solution (3 ml) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. erythrocyte quantity male 0 days 9 44.0 % 1.0 3.0 hematocrit analysis 0.0 0 100442 2479
WKY hematocrit puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. erythrocyte quantity male 0 days 8 44.0 % 1.0 2.83 hematocrit analysis 0.0 PA IV 50mg/kg 490 days 100443 2479
MW hematocrit right nephrectomy (for 56 days) then enalapril (20 mg/kg/d) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. erythrocyte quantity male 0 days 9 47.3 % 0.9 2.7 hematocrit analysis 0.0 ~5/6 to 7/8 nephrectomy 56 days 100851 2523
MW hematocrit right nephrectomy (for 56 days) then angiotensin II receptor antagonist (20 mg/l) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. erythrocyte quantity male 0 days 7 44.5 % 2.4 6.35 hematocrit analysis 0.0 ~5/6 to 7/8 nephrectomy 56 days 100853 2523
MW hematocrit right nephrectomy (for 112 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. erythrocyte quantity male 0 days 6 41.2 % 1.7 4.16 hematocrit analysis 0.0 ~5/6 to 7/8 nephrectomy 112 days 100855 2523
MWF hematocrit cyclosporine A (50 mg/kg/d) (for 7 days) Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4. erythrocyte quantity male 133 days-147 days 6 49.0 % 0.41 1.0 hematocrit analysis 0.0 0 110019 3163
SD-Cftrem1Apb hematocrit control condition McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. erythrocyte quantity not specified 0 days 0 51.0 % 4.0 hematocrit analysis 0.0 0 111448 3184
Sah:SD mean corpuscular volume control condition McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. erythrocyte size trait not specified 0 days 0 57.5 fl 0.5 hematocrit analysis 0.0 0 111444 3184
HsdCpb:WU hematocrit sham surgical control condition Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. erythrocyte quantity male 175 days 10 47.8 % 0.6 1.9 hematocrit analysis 0.0 0 108802 3130
MWF/Hsd hematocrit sham surgical control condition Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. erythrocyte quantity male 175 days 9 45.0 % 0.8 2.4 hematocrit analysis 0.0 0 108804 3130
SHRSP.WKY-(D1Wox29-D1Arb21)/Izm hematocrit control condition Yao H, et al., Physiol Genomics. 2007 Feb 27;. erythrocyte quantity male 70 days-84 days 7 43.0 % 0.38 1.0 hematocrit analysis 0 0 65526 567
SR/Jr hematocrit controlled sodium chloride content diet (8 %) (for 35 days) Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404. erythrocyte quantity male 63 days 13 43.5 % 0.5 1.8 hematocrit analysis 0.0 0 103267 2802
SR/Hsd hematocrit artificial cerebrospinal fluid with 0.15 M sodium (4.4-4.6 ul/hr) (for 14 days) Huang BS, et al., Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H517-24. doi: 10.1152/ajpheart.00651.2004. Epub 2004 Sep 30. erythrocyte quantity male 49 days-56 days 0 38.0 % 2.0 hematocrit analysis 0.0 0 - 103230 2801
MW hematocrit right nephrectomy (for 112 days) then enalapril (20 mg/kg/d) (for 56 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. erythrocyte quantity male 0 days 9 44.6 % 1.0 3.0 hematocrit analysis 0.0 ~5/6 to 7/8 nephrectomy 112 days 100858 2523
MW hematocrit right nephrectomy (for 112 days) then lisinopril (10 mg/kg/d) (for 56 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. erythrocyte quantity male 0 days 10 44.0 % 1.0 3.16 hematocrit analysis 0.0 ~5/6 to 7/8 nephrectomy 112 days 100859 2523
BDIX/CrCrl hematocrit DHD/K12/TRb cells (1.5 X 10E6) Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. erythrocyte quantity male 56 days 20 47.6 % 0.02 0.1 hematocrit analysis 0.0 0 red blood cell count, hematocrit 107810 3097
BDIX/CrCrl hematocrit DHD/K12/TRb cells (1.5 X 10E6) then sanguinarine (5 mg/kg/d) Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. erythrocyte quantity male 71 days 10 52.7 % 0.7 2.2 hematocrit analysis 0.0 0 red blood cell count, hematocrit 107812 3097
MWF hematocrit cyclosporine A (50 mg/kg/d) (for 7 days) and lacidipine (1 mg/kg/d) (for 7 days) Fassi A, etal., Am J Kidney Dis. 1999 Feb;33(2):267-75. doi: 10.1016/s0272-6386(99)70299-4. erythrocyte quantity male 133 days-147 days 7 49.0 % 0.38 1.0 hematocrit analysis 0.0 0 110020 3163
HsdCpb:WU hematocrit control condition Szymanski MK, etal., Basic Res Cardiol. 2012 Mar;107(2):242. doi: 10.1007/s00395-011-0242-4. Epub 2012 Jan 19. erythrocyte quantity male 84 days 5 47.6 % 0.4 0.89 hematocrit analysis 0.0 0 108784 3130
SD-Cftrem1Apb mean corpuscular volume control condition McCarron A, et al., Am J Pathol. 2020 May;190(5):977-993. doi: 10.1016/j.ajpath.2020.01.009. Epub 2020 Feb 18. erythrocyte size trait not specified 0 days 0 59.33 fl 1.67 hematocrit analysis 0.0 0 111445 3184
MNS/Gib hematocrit control condition Ferrari P, etal., J Hypertens. 1987 Apr;5(2):199-206. doi: 10.1097/00004872-198704000-00011. erythrocyte quantity not specified 50 days-70 days 6 48.0 % 0.4 0.98 hematocrit analysis 0.0 0 110328 3169